Phase II study of radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced indolent non-Hodgkin lymphoma

被引：0

作者：

Bethge, W. A. ^{[1
]}

Lange, T. ^{[2
]}

von Harsdorf, S. ^{[3
]}

Bornhaeuser, M. ^{[4
]}

Federmann, B. ^{[1
]}

Stadler, M. ^{[5
]}

Uharek, L. ^{[6
]}

Stelljes, M. ^{[7
]}

Knop, S. ^{[8
]}

Wulf, G. ^{[9
]}

Dittmann, H. ^{[1
]}

Faul, C. ^{[1
]}

Vogel, W. ^{[1
]}

Kanz, L. ^{[1
]}

Bunjes, D. ^{[3
]}

机构：

[1] Univ Tubingen, Tubingen, Germany

[2] Univ Leipzig, Leipzig, Germany

[3] Univ Ulm, Ulm, Germany

[4] Univ Dresden, Dresden, Germany

[5] Leibniz Univ Hannover, Hannover, Germany

[6] Charite, Berlin, Germany

[7] Univ Munster, Munster, Germany

[8] Univ Wurzburg, Wurzburg, Germany

[9] Univ Gottingen, Gottingen, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S44 / S44

页数：1